Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an application to the U.S. Food and Drug Administration (FDA) for review of its ...
Vaccine maker Moderna, Inc. (MRNA) said on Wednesday that it has withdrawn its application to the U.S. Food and Drug Administration (FDA) for approval of its seasonal flu-COVID combination vaccine ...